"Zentrale Notaufnahme: 24 Stunden geöffnet"

During the past decade, Oberhavelkliniken Hennigsdorf conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oberhavelkliniken Hennigsdorf" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Genzyme, a Sanofi Company" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Janssen-Cilag International NV" with 1 trials sponsored and "Janssen-Cilag Ltd." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oberhavelkliniken Hennigsdorf" #1 collaborator was "Bayer" with 2 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator and "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Oberhavelkliniken Hennigsdorf" are "Depressive Disorder, Major" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Chronic Heart Failure" (1 trials), "Depression" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Oberhavelkliniken Hennigsdorf" in a lesser frequency.

Most popular intervention types in "Oberhavelkliniken Hennigsdorf" are "Device" (4 trials), "Biological" (2 trials), "Drug" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Interferon beta-1a" (2 trials), "SSRI/SNRI" (2 trials), "Alemtuzumab" (1 trials), "Alemtuzumab 12 mg" (1 trials) and "Alemtuzumab 24 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oberhavelkliniken Hennigsdorf" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Oberhavelkliniken Hennigsdorf". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Oberhavelkliniken Hennigsdorf, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oberhavelkliniken Hennigsdorf, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".